5-94384466-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -11 ACMG points: 0P and 11B. BP4_ModerateBP6BS1BS2
The NM_001145678.3(KIAA0825):c.3620-8A>G variant causes a splice region, splice polypyrimidine tract, intron change. The variant allele was found at a frequency of 0.0178 in 1,547,060 control chromosomes in the GnomAD database, including 331 homozygotes. In-silico tool predicts a benign outcome for this variant. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (no stars).
Frequency
Genomes: 𝑓 0.014 ( 23 hom., cov: 32)
Exomes 𝑓: 0.018 ( 308 hom. )
Consequence
KIAA0825
NM_001145678.3 splice_region, splice_polypyrimidine_tract, intron
NM_001145678.3 splice_region, splice_polypyrimidine_tract, intron
Scores
2
Splicing: ADA: 0.05135
1
Clinical Significance
Conservation
PhyloP100: 5.57
Genes affected
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -11 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.31).
BP6
Variant 5-94384466-T-C is Benign according to our data. Variant chr5-94384466-T-C is described in ClinVar as [Benign]. Clinvar id is 3038019.Status of the report is no_assertion_criteria_provided, 0 stars.
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.0143 (2177/152212) while in subpopulation SAS AF= 0.0245 (118/4824). AF 95% confidence interval is 0.0209. There are 23 homozygotes in gnomad4. There are 1055 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 23 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KIAA0825 | NM_001145678.3 | c.3620-8A>G | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | ENST00000682413.1 | NP_001139150.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KIAA0825 | ENST00000682413.1 | c.3620-8A>G | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | NM_001145678.3 | ENSP00000506760 | A1 | ||||
KIAA0825 | ENST00000513200.7 | c.3616-4A>G | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | 5 | ENSP00000424618 | A1 | ||||
KIAA0825 | ENST00000703867.1 | c.3631-4A>G | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | ENSP00000515512 | P4 |
Frequencies
GnomAD3 genomes AF: 0.0143 AC: 2176AN: 152092Hom.: 22 Cov.: 32
GnomAD3 genomes
AF:
AC:
2176
AN:
152092
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0180 AC: 2833AN: 157424Hom.: 32 AF XY: 0.0194 AC XY: 1609AN XY: 83128
GnomAD3 exomes
AF:
AC:
2833
AN:
157424
Hom.:
AF XY:
AC XY:
1609
AN XY:
83128
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0181 AC: 25288AN: 1394848Hom.: 308 Cov.: 28 AF XY: 0.0187 AC XY: 12883AN XY: 688198
GnomAD4 exome
AF:
AC:
25288
AN:
1394848
Hom.:
Cov.:
28
AF XY:
AC XY:
12883
AN XY:
688198
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0143 AC: 2177AN: 152212Hom.: 23 Cov.: 32 AF XY: 0.0142 AC XY: 1055AN XY: 74400
GnomAD4 genome
AF:
AC:
2177
AN:
152212
Hom.:
Cov.:
32
AF XY:
AC XY:
1055
AN XY:
74400
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
24
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
KIAA0825-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Nov 20, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
Find out detailed SpliceAI scores and Pangolin per-transcript scores at